ACNE PRONE
- Manufacturer
- Biological Health Group Corporation | Deserving Health International Corp
- Effective date
- 2023-05-24
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:30:14
Label at a glance#
ProductACNE PRONE
Active ingredientSALICYLIC ACID
Label structure9 sections
Contacts and useful links#
Websitewww.deserving-health.com
www.deserving-health.com
www.deserving-health.comLabel contents#
Full prescribing information#
Active ingredient Purpose
Salicylic Acid – 1.50% Acne Medication
Purpose
Acne medication
Use
For the treatment of acne
Warnings
For external use only.
OTC - WHEN USING SECTION
When using this product • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time. • Avoid contact with eyes; if contact occurs, rinse thoroughly with water. Avoid contact with eyes; if contact occurs, rinse thoroughly with water.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of the children
If swallowed, get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Directions
• clean the skin thoroughly before applying this product
• cover the entire affected area with a thin layer one to three times daily
• because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
• if bothersome dryness or peeling occurs, reduce application to once a day or every other day.
• May be applied under make-up.
INACTIVE INGREDIENT SECTION
Inactive ingredients: Water, Aloe Vera,Vitamin A,Vitamin E, Tea Tree Essential Oil, Rose Hip Oil, Grapefruit Seed Extract.
Questions?
Call toll-free from US & CA +1-844-881-2882 or visit www.deserving-health.com
Discontinue use if
Discontinue use if excessive skin irritation develops or increase. If irritation persists, consult a health care practitioner. Hypersensitivity, such as allergy, has been known to occur; in which case, discontinue use.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69711-003-03 | 2023-06-08 | C162847 | 48780-1 | 9d75b9d0-45cd-f424-e053-dadaa90a57ce | ACNE PRONE |
| 69711-003-04 | 2023-06-08 | C162847 | 48780-1 | 9d75b9d0-45cd-f424-e053-dadaa90a57ce | ACNE PRONE |
| 69711-003-03 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-45cd-f424-e053-dadaa90a57ce | ACNE PRONE |
| 69711-003-04 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-45cd-f424-e053-dadaa90a57ce | ACNE PRONE |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| SALICYLIC ACID | ACTIVE INGREDIENT | O414PZ4LPZ | 1 | |
| SALICYLIC ACID | ACTIVE MOIETY | O414PZ4LPZ | 1 | |
| .ALPHA.-TOCOPHEROL | INACTIVE INGREDIENT | H4N855PNZ1 | 1 | |
| ALOE VERA LEAF | INACTIVE INGREDIENT | ZY81Z83H0X | 1 | |
| CITRUS PARADISI SEED | INACTIVE INGREDIENT | 12F08874Y7 | 1 | |
| ROSA CANINA FRUIT OIL | INACTIVE INGREDIENT | CR7307M3QZ | 1 | |
| TEA TREE OIL | INACTIVE INGREDIENT | VIF565UC2G | 1 | |
| VITAMIN A | INACTIVE INGREDIENT | 81G40H8B0T | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- ACNE PRONE
- Salicylic Acid 1.5%
- WATER
- ALOE VERA LEAF
- VITAMIN A
- .ALPHA.-TOCOPHEROL
- TEA TREE OIL
- ROSA CANINA FRUIT OIL
- CITRUS PARADISI SEED
- SALICYLIC ACID
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 69711-003 | 69711-003-04, 69711-003-03 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| WATER | 059QF0KO0R | IACT |
| ALOE VERA LEAF | ZY81Z83H0X | IACT |
| VITAMIN A | 81G40H8B0T | IACT |
| .ALPHA.-TOCOPHEROL | H4N855PNZ1 | IACT |
| TEA TREE OIL | VIF565UC2G | IACT |
| ROSA CANINA FRUIT OIL | CR7307M3QZ | IACT |
| CITRUS PARADISI SEED | 12F08874Y7 | IACT |
| SALICYLIC ACID | O414PZ4LPZ | ACTIB |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | TABLET, CHEWABLE / ORAL | 0.1 mg | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | CAPSULE / ORAL | 16 mg | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | TABLET, FILM COATED / ORAL | 246 mg | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | SOLUTION / ORAL | 1.05 mg/1ml | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | FILM, SOLUBLE / BUCCAL | 0.07 mg | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | SYSTEM / TOPICAL | 0.1 mg | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | TABLET, EXTENDED RELEASE / ORAL | 4 mg | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | TABLET / ORAL | 2 mg | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | OINTMENT / TOPICAL | NA | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 0.64 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 0cdad7b4-0d7b-6071-e063-6394a90a88d6 | 18d3a20f-d7cb-3449-e054-00144ff88e88 | 2023-12-19 | Warnings | 18d3a20f-d7cb-3449-e054-00144ff88e88 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.